Garry R. Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Garry R. Smith has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Yan Zhang
Fox Chase Chemical Diversity Center, Inc., Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, PA 18902
2 shared publicationsAllen B. Reitz
Fox Chase Chemical Diversity Center, Inc., Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, PA 18902
1 shared publicationDeborah J. Barlow
Department of Pharmaceutical Sciences, University of New England College of Pharmacy, Portland, Maine, United States
1 shared publicationDouglas E. Brenneman
Advanced Neural Dynamics, Inc., Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, PA 18902
1 shared publicationKaren L. Houseknecht
Department of Pharmaceutical Sciences, University of New England College of Pharmacy, Portland, Maine, United States
1 shared publicationPetr Čapek
Department of Chemistry and Worm Institute of Research and Medicine (WIRM), The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States
1 shared publication
Latest Publications
- Open Access
- 26 November 2013
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 52 (3) , 446-58
Small-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties.
- 26 November 2013
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 52 (3) , 446-58
Open AccessSmall-molecule anticonvulsant agents with potent in vitro neuroprotection and favorable drug-like properties.
- Open Access
- 12 April 2011
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 2 (6) , 288-293
Enhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors through Rational Design
- 12 April 2011
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 2 (6) , 288-293
Open AccessEnhancing the Pharmacokinetic Properties of Botulinum Neurotoxin Serotype A Protease Inhibitors through Rational Design